chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pain in chest, around the heart; Sharp and sudden pains, may happen while breathing occasionally.; Elevated heart rate for the first couple of days after shot; This is a spontaneous report from a non-contactable consumer (patient).  A 22-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in the left arm in Sep2021 (Batch/Lot Number: FC3180) as DOSE 1, SINGLE for COVID-19 immunisation.  Medical history included asthma from an unknown date and unknown if ongoing.  There were no concomitant medications.  The patient previously took amoxicillin and experienced allergies. Vaccine was received in a pharmacy/ drug store. There were no other vaccine received in four weeks and no other medications received in two weeks. The patient did not have COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination.  On 16Sep2021, the patient experienced pain in chest, around the heart (medically significant), sharp and sudden pains, may happen while breathing occasionally, and elevated heart rate for the first couple of days after shot. The pain persisted up until the date of the report. The events resulted in doctor or other healthcare professional office/clinic visit. The events did not require treatment. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Tiredness; Injection arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tiredness) and VACCINATION SITE PAIN (Injection arm soreness) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 023M20A) for COVID-19 vaccination.     The patient's past medical history included Breast cancer (left side).   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Jan-2021, the patient experienced FATIGUE (Tiredness) and VACCINATION SITE PAIN (Injection arm soreness). At the time of the report, FATIGUE (Tiredness) and VACCINATION SITE PAIN (Injection arm soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment information was provided.
Increase oral secretions, clear odorless, gulping, decrease responsiveness for 5-10 minutes.
hives on right leg. Hives spread down right leg, a few on left leg. Painful. No itching, no treatment.
1640. Tdap to RA, GARDASIL to LA. At approx 1641, pt c/o left arm pain. Become pale while sitting on edge of table. Assisted to lying position, pale, cool & moist. Doesn't respond to commands. Jerking motions noted to arms. Episode lasted x 30sec approx. After episode, pt lethargic and pale. BP 120/60. 1700 - c/o weak & tired. At 1705, HOB elevated, snacks on crackers. 1715 Pt  A & O, BP stable. Dc'd to mom.
Swelling in the area of injection, muscle pain, back pain, redness approx. 5 in from injection site.
Numbness accompanied by tingling sensation in right thumb and weakness in thumb. Feels like nerve damage. It had onset the morning after the vaccination and lasted with varying intensity for about three days. Completely resolved.
A person that I spent time with tested positive for COVID-19 on May 22nd. I began having symptoms on 05/24/2022. Symptoms have been mild with no fever, but having sore throat, running nose, and fatigue. I tested positive on 05/26/2022.
Sore arm related to the immune response; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 67-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 28th December 2021, the patient received the 2nd dose of Shingrix. In December 2021, less than a day after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was not recovered/not resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were as follows: The patient self reported the case. The patient was in perfect shape and was not taking any medications. The patient had sore arm  in relation to the immune response after 2nd dose but felt fine.  The patient asked if patient could do exercise and normal push-ups, light weights, long walk. as it had been about 18 hours. The patient just wanted general information on exercise if patient had no serious side effects. The patient had read package insert but to no avail. The patient did not want to share personal information.
Large red hard lump on left arm at shot location.  Area was painful and itchy. Fatigue, Nausea, Severe headache, chills, muscle pain
Patient received vaccines on Monday. Mom noticed rash on Tuesday. Went to ED on Tuesday, area marked and instructed to come to PCP if area went outside marks.  Area measured here in clinic today 5 in x 7 in. Patient denis any discomfort. Full ROM. Tx--from ED--benadryl and warm compresses. Tx --from clinic Bactrim began.
Stiffness all over; Constipation; Somehow my body seems to be slowing down; Felt cold; Loss of weight; Hair loss; blazing red itchy rash on my upper shot arm; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Stiffness all over), CONSTIPATION (Constipation), BRADYKINESIA (Somehow my body seems to be slowing down), FEELING COLD (Felt cold) and WEIGHT DECREASED (Loss of weight) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy. Concomitant products included METOPROLOL TARTRATE (METAPRO [METOPROLOL TARTRATE]) for TIA, CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE (CANDEMOX [CANDESARTAN CILEXETIL;HYDROCHLOROTHIAZIDE]) for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced RASH PRURITIC (blazing red itchy rash on my upper shot arm). On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiffness all over), CONSTIPATION (Constipation), BRADYKINESIA (Somehow my body seems to be slowing down), FEELING COLD (Felt cold), WEIGHT DECREASED (Loss of weight) and ALOPECIA (Hair loss). The patient was treated with METHYLCELLULOSE (CITRUCEL) for Constipation, at an unspecified dose and frequency. On 05-Mar-2021, RASH PRURITIC (blazing red itchy rash on my upper shot arm) had resolved. At the time of the report, MUSCULOSKELETAL STIFFNESS (Stiffness all over), CONSTIPATION (Constipation) and BRADYKINESIA (Somehow my body seems to be slowing down) had not resolved, FEELING COLD (Felt cold) and WEIGHT DECREASED (Loss of weight) outcome was unknown and ALOPECIA (Hair loss) had resolved.            Most recent FOLLOW-UP information incorporated above includes: On 23-Aug-2021: Follow up received on 23 AUG 2021: Medical history, concomitant and treatment medications added, new events and outcomes were added
This spontaneous report was received from a physician referring to a 20-year-old female patient. The patient's medical history, concomitant medications, drug allergies, or reactions were not reported. On an unspecified day in 2006, the patient was vaccinated with measles, mumps, and rubella (Wistar RA 27-3) virus vaccine, live (M-M-R II), one dosage form for prophylaxis (frequency, strength, route of administration, lot number, and expiry date were not reported). Other suspect therapies included sars-cov-2 vaccine (unspecified) (dose, frequency, strength, administration route, lot number, indication, and expiry date were not reported). On an unknown date, the patient experienced severe hives (urticaria), Stevens-Johnson syndrome, polyethylene glycol allergy (allergy to chemicals), and anaphylactic reaction. The outcome of an anaphylactic reaction, allergy to chemicals, and urticaria was unknown. The outcome of the Stevens-Johnson syndrome was reported as recovered/resolved. The reporter did not assess a causality relationship between the events and the suspect therapies. Upon internal review, the events of the Stevens-Johnson syndrome and anaphylactic reaction were determine to be medically significant.
Patient called clinic 10/17/08 with complaint of area of redness about 4" long (L) arm 4" hardened/swollen area about size of two half dollars, after pneumococcal vaccine on 10/15/08, supportive care advice given, patient contacted on 10/20/08 and noted has complete resolution of symptoms.
Site: Itching at Injection Site-Severe, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: PT WENT TO DOC OFFICE 03/08 RECEIVED ANTIBIOTIC, SWELLING IMPROVED BY 03/10, PT WENT TO EMERGENCY ROOM 03/12 SWELLING INCREASED AND SPREAD AROUND ARM, PT ALSO RECEIVED DIFFERENT ANTIBIOTIC
This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (2 days expired moderna vaccine) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination. No Medical History information was reported. On 08-Nov-2021 at 11:00 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (2 days expired moderna vaccine). On 08-Nov-2021, EXPIRED PRODUCT ADMINISTERED (2 days expired moderna vaccine) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.Reporter stated that no side effect experienced by the patient . No concomitant medications were reported. No treatment medications were reported. Vials were taken out of freezer on the same day doses were administered (08-Nov-2021). Patient had received booster dose. Most recent FOLLOW-UP information incorporated above includes: On 12-Nov-2021: Non-significant follow up received, address and contact information updated. On 12-Nov-2021: Significant follow up received, patient's demographics, vaccination details and event verbatim updated.
6OCT96 woke up in AM rt arm swollen, reddened, tender to touch w/ inc skin temp;no fever;problem worsened w/redness, swelling & tenderness in rt arm @ inj site;rx w/Keflex, Seldane, Voltaren & ice packs as needed;
On 2/1/11 received DTAP #4 left thigh IM, HIB #4 L (L) thigh IM, varicella #1, (R) thigh SQ as documented by medical assistant. Seen in office 2/10/11 with right thigh with 2 x 2 cm red lesion that was warm to touch with mild tenderness. Mom states DTAP given (R) thigh and concerned this lesion is a DTAP reaction.
fever-febrile sz w/MMR lasting 45sec p/vax;lips blue, shaking 9 days a/ lips blue, shaking all over, not breathing well;
These symptoms began at 11:23 am and still present at the time this form is being filled out.  Vertigo Nausea (no vomiting)  Chills (no fever) Tremors Headache   Approximately 5 hours after injection: (still present at time of filling out this form) Pain in left upper arm at injection site down arm. Muscular pain.
Hours after shot encountered severe severe pain deep in left chest and swelling in left breast  Repeated attack next day but 50% less pain Thought I was going to die the first episode pain was relentless, finally dissipated, did not go to hospital   Having pain mild pain in breast and will see the doctor in the next 2 weeks
nausea; vomiting; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer (patient). A female patient of an unspecified age received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation.  Medical history included patient took allergy medications before the 1st dose.  The patient's concomitant medications were not reported.  The patient experienced nausea and vomiting hours after 1st dose, and hesitant to take the 2nd shot. The outcome of events was unknown.   Information on Lot/Batch number has been requested.
Patient was taking the oral typhoid vaccine that was prescribed by our office and purchased at pharmacy. She took the first dose on 4/5/2017 and had a headache, then the next dose on 4/7/2019 another headache. The third dose on 4/9/2017 caused the feeling of swelling in her throat, stomach pain and headache with shaking present.  Patient then used her rescue inhaler thinking it was her allergies. Patient thought at first it was possibly something she ate, called her primary doctor and was advised not to take the last capsule.
patient presented to the office for second dose of HPV vaccine. Patient was administered Meningococcal Conjugate MCV4P by mistake. Patient was not due for second dose of vaccine given until age 16. Patients parents were notified immediately. Patient did not and has not experienced any side effects
2am screaming, knees, wrist, ankles gave out. head and neck hurting
SUSPECTED VACCINATION FAILURE; COVID FIVE MONTHS LATER THE SHOT; This spontaneous report received from a consumer via social media concerned a female of unspecified age, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: UNKNOWN) dose, start therapy date were not reported,1 total administered for prophylactic vaccination. Dose number in series 1. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. It was reported that five months later the shot, the patient had covid (suspected vaccination failure) and could not get the booster until JAN-2022.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the covid five months later the shot and suspected vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with a product quality complaint 90000207491 This case, from the same reporter is linked to 20211237969.; Sender's Comments: V0:20211238440-covid-19 vaccine ad26.cov2.s- suspected clinical vaccination failure . This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS
This spontaneous report received from a registered nurse refers to unspecified number of patients with unknown demographics. No medical history was reported. It was reported that since 09-DEC-2015, unspecified number of patients had been vaccinated with improperly stored RECOMBIVAX HB; (dose, route, frequency: unknown, lot number: L025738, expiry date: 14-AUG-2017). No adverse effects was reported. The excursion temperature was reported as 29.8 degrees Fahrenheit (degrees F) for 24 hours. Outcome of excursion was reported as "not supported" and it was also reported that there was no previous temperature excursion. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
soreness at injection site; Joint pain; headache; excessive thirst; cold sores all over lips; scratchy throat; mild post nasal drip; This is a spontaneous report from a contactable other healthcare professional, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 02Apr2021 at 10:00 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included mild congenital pulmonary stenosis, chronic dry eye syndrome, and other food allergies all from an unknown duration. The patient previously took erythromycin (MANUFACTURER UNKNOWN), BACTRIM and doxycycline (MANUFACTURER UNKNOWN) all from an unknown date for an unknown indication and experienced allergy to these drugs. Concomitant medications included ethinylestradiol; segesterone acetate (ANNOVERA), calcium citrate; magnesium citrate (MAG CITRATE), ascorbic acid (VITAMIN C), curcuma longa (TURMERIC), and docosahexaenoic acid (DHA), vitamin B (MANUFACTURER UNKNOWN) and vitamin D (MANUFACTURER UNKNOWN); all taken for an unknown indication and received within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 03Apr2021, the patient experienced joint pain, headache, excessive thirst, cold sores all over lips, scratchy throat, and mild post nasal drip all these symptoms lasting through the fourth day and also experienced soreness at injection site which was mild and last two days. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department, or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events joint pain, headache, excessive thirst, cold sores all over lips, scratchy throat, and mild post nasal drip was not recovered at the time of this report and that of soreness at injection site which was mild was recovered on 05Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be
Pt signed consent to receive J & J vaccine without notifying provider that he received another dose prior to that date. NO adverse effect noted. pt did not have any adverse effects from vaccine given.
Information has been received from a physician concerning an 15 month old Hispanic male (also reported as female) who on 26, Dec 2006 at 2:50 pm was vaccinated subcutaenously with his first dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (+) varicella virus vaccine live (Oka/Merck upgrade process) (lot# 655142/0974F). concomitant therapy included tuberculin purified protein derivative (manufacturer not specified). On 04, Jan 2007, the patient experienced and itchy rash all over his face and other body parts. Treatment with diphenbydramine (BENADRYL) was prescribed. A follow -up visit was scheduled for the next week. No further information to report. there was no product quality complaint involved. follow up information was received from a  doctor indicating that on 04, Jan 2007, the patient woke up with a arythematous, itchy, papular rash which was generalized and also affected the face. There was no difficulty breathing; the patient was afebrile and playful. No laboratory or diagnostic studies were performed. The outcome was reported as recovered. No additional information is expected.
A few seconds after the injection my daughter Had a seizure. She lost total bladder control, her face went stark white, her eyes rolled back into her head, her back arched so severely that I had to hold onto her so she would not fall of the table, her arms and hands were flying in a very unnatural way. This lasted for two to three minutes. When the seizure stopped, patient could not remember anything except it looked like a train was coming towards her very fast and she remembers seeing the headlight of the train almost blinding her. A few minutes later the ambulance arrived and took us to the hospital.
Vaccine clinic at assisted living where the nursing staff prepared all documents including vaccine history.  They were unaware the PT had received his pfizer booster at the clinic on 10/25/21 and therefore the dose today was a 4th dose.  When I noticed the issue, I called nurse at clinic and suggested she contact the family and watch PT for any adverse reactions.
Patient received Moderna first dose on 2/10/2021 and second dose on 3/10/2021.  Patient is not considered immunocompromised.  Patient received Moderna first booster on 11/10/2021 and Pfizer second booster on 4/20/2022.  Patient was administered a third Moderna booster on 5/31/2022.  Third booster given outside of current FDA booster recommendations.
Went in for my depo shot the first week of March and I had my first covid shot March 26th 2021, the second shot on April 16th 2021. About two days later I started to bleed, which is normal with the depo shot, but after the usual amount of bleeding time I thought this isn't right (usually a week). I bled for over a month (6 to 7 weeks)  and firmly believe it is due to the covid vaccine.
Patient received vaccination about 10:30 AM 9/27/10. Late afternoon after dinner felt weak COPD patient. Low Oxygen level Monday morning went to ER received oxygen treatments and nebulizer treatment. She just finished prednisone treatment.
4hrs p/vax screaming, unconsolable >30mins, followed by vomiting & lethargy;
06/13/02 immunizations given. 06/18/02 developed high fever of 105 degrees followed by febrile seizures taken to ER and examined no resting and no abnormal findings. 06/20/02 treated for bilat ear infection with Amoxicillin which was changed to Ceclax 3 days later then changed to Augmentin on 06/24/02. Dc'd due to diarrhea and recently started.
Headache, NauseaVomiting, inj site pain, fatigue, delayed inj site rash after 1 week Narrative:
9/16/10 Patient called reporting muscle aches, local hives & pain, general ill feeling. Advised MD visit or urgent care visit but patient didn't feel she could get to MD or urgent care because of distance so went to local ER. Symptoms included fever (101.2F), leg/neck/back pain, local hives/pain, general ill feeling at ER (per patient report). Overnight observation in ER refused & agreed to MD follow up. Given Morphine at ER & Rx for DILAUDID. Has appointment with MD today.
I ADMINISTERED THE INJECTION AND ABOUT 2 MINUTES AFTER THE PATIENT STATED SHE DID NOT FEEL WELL AND APPREARED TO PASS OUT. SHE WAS SITTING IN A CHAIR AND HER MOTHER WAS PRESENT AS PATIENT IS APPREHENSIVE ABOUT INJECTIONS. SHE THEN SEEMED TO BE MORE COHERENT ALTHOUGH DID NOT FEEL RIGHT STILL AND SHORTLY AFTER APPEARED TO PASS OUT AGAIN. IN THE MEANTIME 911 HAD BEEN CALLED. WE HAD ALSO GOTTEN WATER AND ICE PACKS AS SHE FELT VERY WARM AND WAS DIAPHORETIC. 911 ARRIVED, PATIENT WAS EVALUATED AND WAS MUCH MORE ALERT AND ORIENTED AFTER HAVING A SPELL OF NOT BEING ABLE TO SEE. 911 THEN LEFT AND ALLOWED PATIENT TO LEAVE WITH HER MOTHER
10 days after immunization, developed symptoms of bowel obstruction, including vomiting, abdominal distension, hypoglycemia, and profound dehydration.  Hospitalized, fluid resuscitated, and transferred to tertiary care hospital with diagnosis of enterocolitis.  Another student at same facility received same vaccine (different bottle) on the same day, and also developed bowel obstruction within hours.  (separate report filed this date)